Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Status: Enrolling
Updated:  8/29/2017
Melinta 303 Study Site
mi
from
La Plata,
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Status: Enrolling
Updated: 8/29/2017
Melinta 303 Study Site
mi
from
La Plata,
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Lauderdale Lakes, FL
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Palmetto Bay, FL
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Blackfoot, ID
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Blackfoot, ID
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Lake Charles, LA
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
North Massapequa, NY
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
North Massapequa, NY
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Medford, OR
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Houston, TX
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Pharr, TX
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Pharr, TX
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Marshfield, WI
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Marshfield, WI
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Baulkham Hills,
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Baulkham Hills,
Click here to add this to my saved trials
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Royal Oak, MI
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection
Status: Enrolling
Updated:  8/30/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection
Status: Enrolling
Updated: 8/30/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated:  8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated: 8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg
Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg TR-701 Free Acid in Healthy Volunteers
Status: Enrolling
Updated:  8/30/2017
Trius Investigator Site 001
mi
from
Hartford, CT
Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg
Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg TR-701 Free Acid in Healthy Volunteers
Status: Enrolling
Updated: 8/30/2017
Trius Investigator Site 001
mi
from
Hartford, CT
Click here to add this to my saved trials
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Shreveport, LA
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Lima, OH
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Lima, OH
Click here to add this to my saved trials
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated:  8/31/2017
Research Site
mi
from
El Talar,
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
Status: Enrolling
Updated: 8/31/2017
Research Site
mi
from
El Talar,
Click here to add this to my saved trials
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis
Status: Enrolling
Updated:  8/31/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis
Status: Enrolling
Updated: 8/31/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
New York, NY
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
mi
from
Alassio,
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
mi
from
Alassio,
Click here to add this to my saved trials
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Status: Enrolling
Updated:  9/1/2017
Rockefeller University
mi
from
New York, NY
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Status: Enrolling
Updated: 9/1/2017
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
Rehabilitation R&D Service, Baltimore, MD
mi
from
Baltimore, MD
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Rehabilitation R&D Service, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD
mi
from
Perry Point, MD
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD
mi
from
Perry Point, MD
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated:  9/6/2017
Washington DC VA Medical Center, Washington, DC
mi
from
Washington, D.C.,
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Washington DC VA Medical Center, Washington, DC
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Antifungal Locks to Treat Fungal-related Central Line Infections
The Use of Antifungal Lock Therapy in Intestinal Failure and Other Patients
Status: Enrolling
Updated:  9/10/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Antifungal Locks to Treat Fungal-related Central Line Infections
The Use of Antifungal Lock Therapy in Intestinal Failure and Other Patients
Status: Enrolling
Updated: 9/10/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated:  9/12/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated: 9/12/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated:  9/12/2017
Duke University
mi
from
Durham, NC
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated: 9/12/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
A Phase 1, Randomized, Dose-escalation Study to Evaluate the Safety and Immunogenicity of the ID93 + GLA-SE Vaccine at Two Dose Levels of the ID93 Antigen and the GLA-SE Adjuvant in Healthy Adults
Status: Enrolling
Updated:  9/14/2017
Johnson County Clin-Trials
mi
from
Lenexa, KA
Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
A Phase 1, Randomized, Dose-escalation Study to Evaluate the Safety and Immunogenicity of the ID93 + GLA-SE Vaccine at Two Dose Levels of the ID93 Antigen and the GLA-SE Adjuvant in Healthy Adults
Status: Enrolling
Updated: 9/14/2017
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
A Phase 1, Randomized, Double Blind Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
Status: Enrolling
Updated:  9/14/2017
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
A Phase 1, Randomized, Double Blind Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
Status: Enrolling
Updated: 9/14/2017
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Click here to add this to my saved trials
Human Breastmilk in Young Children With Norovirus Infection of the Gut
A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut
Status: Enrolling
Updated:  9/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Human Breastmilk in Young Children With Norovirus Infection of the Gut
A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut
Status: Enrolling
Updated: 9/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
University of Chicago Medicine
mi
from
Chicago, IL
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
University of Chicago Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
Wayne State University School of Medicine
mi
from
Detroit, MI
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
Wayne State University School of Medicine
mi
from
Detroit, MI
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
Cleveland Clinic
mi
from
Cleveland, OH
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
UMASS Memorial Medical Center
mi
from
Worcester, MA
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
University Health Network
mi
from
Toronto,
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
University Health Network
mi
from
Toronto,
Click here to add this to my saved trials
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated:  9/18/2017
City of Hope
mi
from
Duarte, CA
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Status: Enrolling
Updated: 9/18/2017
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
mi
from
Antioch, CA
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
mi
from
Antioch, CA
Click here to add this to my saved trials
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
mi
from
Daly City, CA
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
mi
from
Daly City, CA
Click here to add this to my saved trials
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
mi
from
Fremont, CA
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered to at Risk Subjects From 1 to Less Than 18 Years
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
mi
from
Fremont, CA
Click here to add this to my saved trials